Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
JYNT Stock Forecast 2026-2027
$8.58
Current Price
$122.89M
Market Cap
Buy 1
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to JYNT Price Targets
+39.9%
To High Target of $12.00
+4.9%
To Median Target of $9.00
+4.9%
To Low Target of $9.00
JYNT Price Momentum
-5.5%
1 Week Change
+4.5%
1 Month Change
-12.4%
1 Year Change
-1.6%
Year-to-Date Change
-36.3%
From 52W High of $13.47
+14.4%
From 52W Low of $7.50
📊 TOP ANALYST CALLS
Did JYNT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Joint Corp is one of their latest high-conviction picks.
Latest JYNT Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, JYNT has a neutral consensus with a median price target of $9.00 (ranging from $9.00 to $12.00). The overall analyst rating is Buy (7.0/10). Currently trading at $8.58, the median forecast implies a 4.9% upside. This outlook is supported by 1 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Linda Bolton Weiser at DA Davidson, projecting a 39.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
JYNT Analyst Ratings
1
Buy
3
Hold
0
Sell
JYNT Price Target Range
Low
$9.00
Average
$9.00
High
$12.00
Current: $8.58
Latest JYNT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for JYNT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 8, 2025 | B. Riley Securities | Jeff Van Sinderen | Buy | Maintains | $18.00 |
| May 9, 2025 | Lake Street | Ryan Meyers | Buy | Maintains | $16.00 |
| Nov 8, 2024 | Roth MKM | George Kelly | Buy | Maintains | $15.00 |
| May 6, 2024 | B. Riley Securities | Jeff Van Sinderen | Buy | Maintains | $20.00 |
| May 3, 2024 | Roth MKM | George Kelly | Buy | Reiterates | $16.00 |
| Sep 14, 2023 | Roth MKM | George Kelly | Buy | Maintains | $13.00 |
| Aug 11, 2023 | Roth MKM | Buy | Maintains | $N/A | |
| Aug 11, 2023 | Maxim Group | Hold | Downgrade | $N/A | |
| Mar 13, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Upgrade | $15.00 |
| Aug 8, 2022 | DA Davidson | Linda Bolton Weiser | Underperform | Maintains | $12.00 |
| Aug 5, 2022 | Maxim Group | Anthony Vendetti | Buy | Upgrade | $36.00 |
| Aug 5, 2022 | B. Riley Securities | Jeff Van Sinderen | Buy | Upgrade | $31.00 |
| May 10, 2022 | DA Davidson | Linda Bolton Weiser | Underperform | Downgrade | $13.00 |
| May 9, 2022 | DA Davidson | Linda Bolton Weiser | Underperform | Downgrade | $13.00 |
| May 6, 2022 | Craig-Hallum | Hold | Downgrade | $N/A | |
| Feb 25, 2022 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $69.00 |
| Aug 9, 2021 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $128.00 |
| Aug 6, 2021 | Roth Capital | George Kelly | Buy | Maintains | $105.00 |
| Jun 28, 2021 | Roth Capital | George Kelly | Buy | Maintains | $100.00 |
| Jun 3, 2021 | Maxim Group | Hold | Downgrade | $N/A |
The Joint Corp. (JYNT) Competitors
The following stocks are similar to Joint Corp based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
JYNT
Joint Corp
mkt cap
132.06M
The Joint Corp. (JYNT) Financial Data
The Joint Corp. has a market capitalization of $122.89M with a P/E ratio of 66.0x. The company generates $54.90M in trailing twelve-month revenue with a 5.3% profit margin.
Revenue growth is +3.1% quarter-over-quarter, while maintaining an operating margin of +4.2% and return on equity of -1.5%.
Valuation Metrics
Market Cap
$122.89M
Enterprise Value
$108.57M
P/E Ratio
66.0x
PEG Ratio
-0.5x
Price/Sales
2.4x
Growth & Margins
Revenue Growth (YoY)
+3.1%
Gross Margin
+81.4%
Operating Margin
+4.2%
Net Margin
+5.3%
EPS Growth
+5,510.5%
Financial Health
Cash/Price Ratio
+19.5%
Current Ratio
1.6x
Debt/Equity
13.3x
ROE
-1.5%
ROA
-0.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Joint Corp. (JYNT) Business Model
About The Joint Corp.
What They Do
Provides affordable chiropractic care through clinics.
Business Model
The company operates on a franchise model, allowing it to expand its network of clinics that provide chiropractic services without the need for insurance or appointments. It generates revenue through a subscription-based model, ensuring consistent income while offering continuous care to its clients.
Additional Information
The Joint Corp. focuses on back, neck, and osteopathic health, catering to the rising demand for non-invasive healthcare alternatives. Its innovative approach and customer-centric services position it as a notable entity in the healthcare and wellness industries.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
202
CEO
Mr. Sanjiv Razdan
Country
United States
IPO Year
2014
Website
www.thejoint.comThe Joint Corp. (JYNT) Latest News & Analysis
Latest News
Quick Summary
The Joint Corp. (NASDAQ: JYNT) has appointed Michelle Reap as director of franchise development to support its growth strategy.
Why It Matters
Michelle Reap's appointment signals potential growth for The Joint Corp. as it enhances franchise development, which may lead to increased market expansion and revenue.
Source: PRNewsWire
Market Sentiment:
Neutral
The Joint Chiropractic and Subaru of Utah Partner to Bring Chiropractic Care to over 275 Employees
15 days ago
Quick Summary
The Joint Corp. (NASDAQ: JYNT) partnered with Miller Subaru in Utah to offer chiropractic care at preferred pricing for about 275 employees, enhancing their wellness options.
Why It Matters
The partnership expands The Joint's customer base and enhances employee wellness programs, potentially increasing revenue and improving employee satisfaction, which could boost stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
The Joint Corp. (JYNT) held its Q4 2025 earnings call, discussing financial performance and future outlook. Details on revenue and growth strategies were provided.
Why It Matters
The earnings call provides insights into The Joint Corp.'s financial performance and future outlook, influencing stock valuation and investor sentiment on its growth potential.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
The Joint Corp. (JYNT) reported quarterly earnings of $0.06 per share, surpassing the Zacks Consensus Estimate of $0.05, matching last year's earnings.
Why It Matters
The Joint Corp.'s earnings beat expectations, indicating strong performance and potential growth, which may boost investor confidence and positively impact stock price.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Joint Corp. (NASDAQ: JYNT) will report its Q4 and full-year 2025 financial results on March 12, 2026, after market close, followed by a conference call at 5:00 p.m. ET.
Why It Matters
The upcoming earnings report and conference call will provide key insights into The Joint Corp.'s financial performance and strategic direction, influencing stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A new executive with over 30 years of experience in operational enhancement for major franchisors across various industries has joined a company, potentially indicating strategic growth initiatives.
Why It Matters
The executive's extensive experience in operational enhancement signals potential for improved efficiency and profitability, likely boosting investor confidence in the company's growth prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About JYNT Stock
What is The Joint Corp.'s (JYNT) stock forecast for 2026?
Based on our analysis of 6 Wall Street analysts, The Joint Corp. (JYNT) has a median price target of $9.00. The highest price target is $12.00 and the lowest is $9.00.
Is JYNT stock a good investment in 2026?
According to current analyst ratings, JYNT has 1 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.58. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for JYNT stock?
Wall Street analysts predict JYNT stock could reach $9.00 in the next 12 months. This represents a 4.9% increase from the current price of $8.58. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Joint Corp.'s business model?
The company operates on a franchise model, allowing it to expand its network of clinics that provide chiropractic services without the need for insurance or appointments. It generates revenue through a subscription-based model, ensuring consistent income while offering continuous care to its clients.
What is the highest forecasted price for JYNT The Joint Corp.?
The highest price target for JYNT is $12.00 from Linda Bolton Weiser at DA Davidson, which represents a 39.9% increase from the current price of $8.58.
What is the lowest forecasted price for JYNT The Joint Corp.?
The lowest price target for JYNT is $9.00 from at , which represents a 4.9% increase from the current price of $8.58.
What is the overall JYNT consensus from analysts for The Joint Corp.?
The overall analyst consensus for JYNT is neutral. Out of 6 Wall Street analysts, 1 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $9.00.
How accurate are JYNT stock price projections?
Stock price projections, including those for The Joint Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 10:43 AM UTC